GPTX
VC Fund
Wan Chai, Hong Kong
GPTX is a VC fund in Wan Chai focused on Genetics and Wellness. GPTX targets being the leading global expert in digital investment. Licensed by the Securities and Futures Commission of Hong Kong.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries GPTX invests in
Stages GPTX invests in
Countries GPTX invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Gao Ting
|
|||
Investment Focus
Industry
- Genetics 1 (50%)
- Wellness 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Series A 1 (50%)
- Post-IPO Equity 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gao Ting
CEO & Founder
|
CEO & Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Prenetics
|
Prenetics is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed byACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’. | $48M / Post-IPO Equity / Oct 27, 2025 | |
|
Synaptic Technology
|
Synapse Technology is an AI-powered financial service provider that focuses on transforming the financial landscape through cutting-edge artificial intelligence solutions. Committed to creating a dynamic, interconnected financial community, Synapse leverages advanced machine learning algorithms and data analytics to offer personalized, data-drivenfinancial services. | $1.3M / Series A / Jun 10, 2025 |
Co-Investors
American Ventures
1 deal together
AVG Group
1 deal together
DL Holdings Group
1 deal together
Exodus
1 deal together
Kraken
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does GPTX invest in?
GPTX invests primarily in Genetics, Wellness and Health Care startups, most often at Series A and Post-IPO Equity stage. Most of the 2 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact GPTX?
Public channels for GPTX include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at GPTX?
The team at GPTX includes Gao Ting (CEO & Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
